Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma:a Multicenter Real-World Study

被引：0
|
作者：
Liu, Na [1 ]
Wang, Luqun [2 ]
Liu, Rentong [3 ]
Zhong, Yuping [4 ]
Feng, Xianqi [5 ]
Sun, Zhongliang [6 ]
Li, Jie
Meng, Fanjun [7 ]
Ma, Junjie [8 ]
Yuan, Changyong [9 ]
Li, Hao [10 ]
Wang, Ling [11 ]
Xu, Zhilong [12 ]
Yu, Jie [13 ]
Zhang, Hao [14 ]
Chen Chunyan [15 ]
机构：
[1] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[3] Binzhou Med Coll, Affiliated Hosp, Shandong, Peoples R China
[4] Univ Hlth & Rehabil Sci Qingdao Hosp, Qingdao Municipal Hosp, Qingdao, Peoples R China
[5] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China
[6] First Peoples Hosp Jining City, Shandong, Peoples R China
[7] Qingdao Univ, Affiliated Hosp, Qiangdao, Peoples R China
[8] Yantai Yuhuangding Hosp, Yantai, Peoples R China
[9] Shandong Univ, Dezhou Peoples Hosp, Qilu Hosp, Dezhou Hosp, Dezhou City, Peoples R China
[10] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[11] Taian Cent Hosp, Tai An, Shandong, Peoples R China
[12] Lanling Cty Peoples Hosp, Iinyi, Peoples R China
[13] Weihai Municipal Hosp, Weihai, Peoples R China
[14] Jining Med Univ, Affiliated Hosp, Jining, Peoples R China
[15] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment
    Habib, Alma
    Khan, Abdullah Mohammad
    Laharwal, Mehak M.
    Mewawalla, Prerna
    Mckenna, Marshall
    Tiger, Yun Kyoung
    Shaikh, Hira
    Strouse, Christopher
    Green, Kimberly M.
    Davis, James A.
    Hashmi, Hamza
    Snyder, Jordan
    Mahmoudjafari, Zahra
    Mushtaq, Muhammad Umair
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Atrash, Shebli
    Paul, Barry
    Friend, Reed
    BLOOD, 2024, 144 : 7037 - 7038
  • [32] Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World Study
    Quach, Hang
    Yoon, Sung-Soo
    Kim, Kihyun
    Lee, Ji Hyun
    Nagarajan, Chandramouli
    Ho, Phoebe Joy
    Low, Michael S. Y.
    Huang, Wei-Han
    Wong, Raymond
    Liao, Nina
    Lin, ChingFeng
    Britland, Matthew
    Li, Julia
    Chai, Stella
    Kim, Jin Seok
    BLOOD, 2022, 140 : 4264 - 4266
  • [33] An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
    Wu, Hongzhen
    Xie, Tingting
    Yu, Qiao
    Su, Tao
    Zhang, Min
    Wu, Luying
    Wang, Xiaoling
    Peng, Xiang
    Zhi, Min
    Yao, Jiayin
    BIOMEDICINES, 2025, 13 (01)
  • [34] Effectiveness and Safety Analysis of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
    Wu, H.
    Su, T.
    Wu, L.
    Zhi, M.
    Yao, J.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1216 - i1217
  • [35] Front-line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real-world setting: A multicenter retrospective study in China
    Bao, Li
    Liu, Ai-Jun
    Chu, Bin
    Wang, Qian
    Dong, Yu-Jun
    Lu, Min-Qiu
    Shi, Lei
    Gao, Shan
    Wang, Yu-Tong
    Wang, Li-Fang
    Chen, Wen-Ming
    Zhuang, Jun-Ling
    CANCER MEDICINE, 2023, 12 (03): : 3101 - 3111
  • [36] Safety and Efficacy of Belantamab Mafadotin in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
    Dileo, Rachel
    Mewawalla, Prerna
    Patrus, Gina
    Strouse, Christopher
    Chen, Ethan
    Shaikh, Hira
    Davis, James A.
    Green, Kimberly M.
    Alkharabsheh, Omar
    Rashid, Aliya
    Pokhrel, Bidushi
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2024, 144 : 4742 - 4743
  • [37] A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting
    Rifkin, Robert M.
    Medhekar, Rohan
    Amirian, E. Susan
    Aguilar, Kathleen M.
    Wilson, Thomas
    Boyd, Marley
    Mezzi, Khalid
    Panjabi, Sumeet
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 10
  • [38] A Real-World Comparative Analysis of Carfilzomib and Other Systemic Multiple Myeloma Chemotherapies in the US Community Oncology Setting
    Rifkin, Robert M.
    Medhekar, Rohan
    Amirian, E. Susan
    Wilson, Thomas
    Boyd, Marley
    Mezzi, Khalid
    Panjabi, Sumeet
    BLOOD, 2017, 130
  • [39] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [40] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Ofir Zmira
    Alex I. Halpern
    Lital Abraham
    Anat Achiron
    Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
12345